Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia

Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia

Type 2 diabetic mellitus is a multifactorial metabolic disorder affecting huge population around the world. This indicates that there is an urgent unmet need of cost effective, new treatment strategies for type 2 diabetes mellitus with no or less side effects. Phenolic compounds including isoflavone...

Full description

Bibliographic Details
Main Authors: Manisha J. Oza, Yogesh A. Kulkarni
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Pharmacology
Subjects:
type 2 diabetes mellitus
isoflavone
formononetin
SIRT1
high fat diet
streptozotocin
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.00739/full

Similar Items

Similar Items